Orchasp Limited will hold a Board of Directors meeting on August 31, 2026, to consider the issuance of equity shares on a preferential basis. The company plans to allot shares to M/s WAHTULMSYLH LLMQWLAT and bond holders of M/s Global Focus Fund. The move aims to settle accrued interest and fulfill obligations under existing agreements.

The board will also regularize the appointments of three directors for five-year terms, subject to shareholder approval at the 32nd Annual General Meeting (AGM). These include Mrs. Sirisha Pattapurathi as a Non-Executive Non-Independent woman director, alongside Mr. Srinivasu Sunkara and Mr. Ravi Prasad Muthyam as independent directors.

Capital Raise and Strategic Approvals

The primary financial agenda involves equity issuance linked to specific liabilities and partnerships. The board will review the proposal to issue shares to M/s WAHTULMSYLH LLMQWLAT pursuant to a Loan Agreement cum Memorandum of Understanding (MOU). Additionally, shares will be issued to bond holders of M/s Global Focus Fund to address accrued interest requests.

Further strategic approvals include the Loan Agreement cum MOU with Apptest Corporation, USA. The board will also finalize logistics for the 32nd AGM, including the appointment of Ms. T. Durga Pallavi as scrutinizer for e-voting, and fixing record dates and book closure periods.

What the Numbers Show

The decision to settle accrued interest with Global Focus Fund via equity issuance rather than cash suggests a focus on preserving liquidity. By converting debt obligations into equity, Orchasp Limited avoids immediate cash outflows while diluting existing shareholders. This approach aligns with the simultaneous preferential issue to another entity under a loan agreement, indicating a structured strategy to manage creditor relationships through capital restructuring.

Orchasp Limited reported a consolidated net profit of ₹28.00 lakh for the quarter ended June 30, 2026 (Q1FY27), marking a 48% year-on-year decline from ₹54.22 lakh in Q1FY26. The profit contraction followed a sharp 73% drop in revenue from operations, which fell to ₹208.37 lakh from ₹775.19 lakh in the prior year period. While employee benefit expenses decreased significantly to ₹201.34 lakh from ₹671.91 lakh, helping preserve margins, the company’s reliance on other income—surging to ₹63.41 lakh from ₹2.52 lakh—highlighted a divergence between operational performance and total earnings.

The Board of Directors approved the unaudited standalone and consolidated financial results at its meeting held on August 11, 2026, pursuant to Regulation 30(2) and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. However, statutory auditors JMT & Associates issued a qualified opinion on both sets of results. The qualification stems from material uncertainties regarding the carrying value of overseas investments, the recoverability of long-outstanding receivables, and delays in remitting statutory dues up to July 30, 2026.

Auditor Qualifications

The qualified opinion raised by JMT & Associates centers on three primary areas of concern:

• Non-Operational Subsidiary: The company holds an investment of ₹6,825 lakh in its wholly-owned subsidiary, Cybermate International, Unipessoal, LDA, located in Portugal. The subsidiary has been non-operational for over six years and received a notice of cancellation of its Certificate of Incorporation due to non-compliance with statutory filing requirements. Orchasp Limited has transferred these investments to a new US-based subsidiary, Orchasp Inc, but auditors noted insufficient clarity on the new entity’s financial position to assess impairment provisions.

• Aged Receivables and Payables: Trade receivables and payables have remained outstanding for more than six months. In the absence of confirmations for these balances, along with various advances and loans, auditors could not verify their recoverability or payability.

• Statutory Dues: Management attributed the delay in paying Tax Deducted at Source (TDS) and other statutory dues to temporary liquidity constraints and stated it is taking steps to regularize the outstanding amounts.

Financial Performance Highlights

Note: All figures are consolidated unless specified. EPS is not annualized.

What the Numbers Show

The sharp contraction in revenue from operations was largely offset by a disproportionate drop in employee benefit expenses, which fell by 70% year-on-year. While this cost-cutting measure preserved profitability in absolute terms, the reliance on other income—jumping from ₹2.52 lakh to ₹63.41 lakh—highlights a divergence between operational performance and total earnings. The significant investment in the non-operational Portuguese subsidiary remains a balance sheet overhang, with auditors unable to validate its carrying value amidst ongoing regulatory compliance issues abroad.